Lunai Bioworks Inc. — Director's Dealing 2021

Jul 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-07-19

Reporting Person: Dybul Mark (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-19	Option to purchase shares of common stock	$4.57	A	2000000	Acquired	2031-07-19	Common stock (2000000)	Direct

Footnotes

F1: The options vest ratably on July 1, 2022, July 1, 2023 and July 1, 2024.